ENDVOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

ENDONOVO THERAPEUTICS, INC.

Financials through Q3 FY2023, quarter ended Sep 30, 2023Last filing: 10-Q/A on Dec 29, 2023

$0.00+0.00 (0.00%)

Close on Oct 19, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

Endonovo Therapeutics has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Announcements Endonovo Therapeutics filed with the SEC

Parsed from the XBRL in Endonovo Therapeutics's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-1000 reverse split on Dec 20, 2019
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing